A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setti... by Vanita Noronha, MBBS, MD, DM, Nandini S. Menon, MBBS, MD, DrNB, Vijay Maruti Patil, MBBS, MD, DM, M.V. Chandrakanth, MBBS, MD, DM, Sucheta More, BAMS, MSc, Aditya Dhanawat, MBBS, MD, Oindrila Roy Chowdhary, MSc, Ajaykumar Chandrabhan Singh, MBBS, MD, DM, Supriya Goud, BAMS, PGDCR, Srushti Shah, BHMS, PGDCR, Naveen Karuvandan, MBBS, MD, DM, Kunal Naishadh Jobanputra, MBBS, MD, DM, Darshit Kalpeshkumar Shah, DM, Minit Jalan Shah, MBBS, MD, DM, Rupjyoti Sarma, MBBS, MD, DM, Dhwaniben Patel, MBBS, MD, Ritam Joarder, MBBS, MD, Prashant Kumar, MBBS, MD, Anupa John, MBBS, MD, Jaspreet Kaur, MBBS, MD, Saurabh Bagra, MBBS, MD, Nilendu Purandare, MBBS, DNB, Amit Janu, MBBS, DMRD, DNB, Abhishek Mahajan, MBBS, MD, MRes, Kumar Prabhash, MBBS, MD, DM

Get full text